Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVERSIBLE: Prevention of Hypoglycemia in Type 1 Diabetes With Oral Glucose at Higher Thresholds
NCT04876079Completed
- Sponsor
- Montreal Clinical Research Institute
- Start
- Jun 2021
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Open-label trial in type 1 diabetes mellitus (T1D) and hypoglycemia (3 arms), sponsored by Montreal Clinical Research Institute. Primary endpoint: Time spent of glucose levels < 4.0 mmol/L at 60 minutes. Started Jun 2021; status: completed.
02
Conditions
type 1 diabetes mellitus (T1D)hypoglycemia
Beyond the preview
Go deeper on NCT04876079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04876079.